Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
M. Taplin, B. Montgomery, C. Logothetis, et al.. (2014). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 246 times. https://doi.org/10.1200/JCO.2013.53.4578
